Breast cancer is traditionally classified into four groups based on immunohistochemical expression of hormone receptors: estrogen receptor positive (ER+), progesterone receptor positive (PR+), human epidermal growth factor receptor positive (HER2+), and triple-negative (TNBC), characterized by the absence of any of the above receptors. Here, PGR is linked to breast carcinoma.